LYN-00301

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameLYN-00301

Drug Alias NameLYN-00301

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody

Mechanisms of ActionAntibody-dependent cell-mediated cytotoxicity (ADCC) effectsCluster of differentiation 47 inhibitorsT lymphocytes stimulants

TargetsCluster of differentiation 47

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesLynkcell Inc

China Registration ClassN/A

Active CompaniesLynkcell Inc

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

ATC CodeN/A